Bayer Aktiengesellschaft (BAYZF)
| Previous close | 29.48 |
| Open | 26.91 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 26.91 - 29.30 |
| 52-week range | 26.91 - 64.93 |
| Volume | |
| Avg. volume | 33,667 |
| Market cap | 28.785B |
| Beta (5Y monthly) | 0.97 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.12 (0.40%) |
| Ex-dividend date | 29 Apr 2024 |
| 1y target est | N/A |
- Reuters
Bayer's Monsanto wins reversal of $185 million PCBs verdict in Washington court
A Washington state appeals court on Wednesday overturned a $185 million verdict against Bayer's Monsanto unit over chemical contamination at a Seattle-area school, marking the second big legal win for the company in as many weeks. Monsanto spinoff Pharmacia, which sold now-banned chemicals called polychlorinated biphenyls, was found liable in 2021. Three teachers claimed they suffered brain damage from PCBs that leaked from light fixtures at the Sky Valley Education Center in Monroe, Washington.
- GuruFocus.com
Bayer AG's Dividend Analysis
Bayer AG (BAYRY) recently announced a dividend of $0.03 per share, payable on 2024-05-13, with the ex-dividend date set for 2024-04-29. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Bayer AG's dividend performance and assess its sustainability.
- Zacks
Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Roche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue to decline. The top line suffers due to the appreciation of the Swiss franc against most currencies.
